Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8563)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2022 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mattos ÂZ, Debes JD, Vogel A, Arrese M, Revelo X, Pase THS, Manica M, Mattos AA. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy? . World J Gastroenterol 2022; 28(28): 3595-3607 [PMID: 36161041 DOI: 10.3748/wjg.v28.i28.3595] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3595.htm |
| Number | Citing Articles |
| 1 |
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2024; 22(9): 1774 doi: 10.1016/j.cgh.2024.03.028
|
| 2 |
Haoqiang Yang, Jinghui Li, Yiting Niu, Tao Zhou, Pengyu Zhang, Yang Liu, Yanjun Li. Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1494788
|
| 3 |
Jean-Baptiste Barbe-Richaud, Fabien Moinard-Butot, Stéphanie Husson-Wetzel, Marion Bolliet, Pascale Chiappa, Christine Belletier, Mathieu Ribeiro, Elodie Poprawa, Cécile Bigot, Armand Abergel, Meher Ben Abdelghani. Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study. Journal of Hepatocellular Carcinoma 2025; : 1279 doi: 10.2147/JHC.S521130
|
| 4 |
Sainan Tang, Shanshan Wu, Wenzhe Zhang, Lili Ma, Li Zuo, Hua Wang. Immunology and treatments of fatty liver disease. Archives of Toxicology 2025; 99(1): 127 doi: 10.1007/s00204-024-03920-1
|
| 5 |
Yi Yuan, Dailin Wu, Jing Li, Dan Huang, Yan Zhao, Tianqi Gao, Zhenjie Zhuang, Ying Cui, Da-Yong Zheng, Ying Tang. Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1217400
|
| 6 |
Andrea del Pilar Abreo Medina, Mengdie Shi, Yanyan Wang, Zhongyu Wang, Kehe Huang, Yunhuan Liu. Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 2025; 73(5): 2717 doi: 10.1021/acs.jafc.4c09209
|
| 7 |
Ziwei Guo, Ziang Yao, Bohao Huang, Dongjie Wu, Yanbo Li, Xiaohan Chen, Yanping Lu, Li Wang, Wenliang Lv. MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy. International Immunopharmacology 2024; 140: 112821 doi: 10.1016/j.intimp.2024.112821
|